157 related articles for article (PubMed ID: 23531907)
21. Treatment of indolent lymphoma in Germany - results of a representative population-based survey.
Schmidt C; Fetscher S; Görg C; Kornek P; Nusch A; Kegel T; Kellermann L; Hiddemann W; Fingerle-Rowson G; Dreyling M
Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):204-11. PubMed ID: 21575925
[TBL] [Abstract][Full Text] [Related]
22. [Medicinal therapy of malignant lymphomas].
Aul C; Schroeder M; Giagounidis A
Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
[TBL] [Abstract][Full Text] [Related]
23. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Young RC; Longo DL; Glatstein E; Ihde DC; Jaffe ES; DeVita VT
Semin Hematol; 1988 Apr; 25(2 Suppl 2):11-6. PubMed ID: 2456618
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
25. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
Nakamura S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
[TBL] [Abstract][Full Text] [Related]
26. [WHO-classification of malignant lymphomas].
Rüdiger T; Müller-Hermelink HK
Radiologe; 2002 Dec; 42(12):936-42. PubMed ID: 12486547
[TBL] [Abstract][Full Text] [Related]
27. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
28. Lymphoma in older patients.
Thieblemont C; Coiffier B
J Clin Oncol; 2007 May; 25(14):1916-23. PubMed ID: 17488991
[TBL] [Abstract][Full Text] [Related]
29. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
30. Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas.
Ahmadi T; Chong EA; Gordon A; Aqui NA; Nasta SD; Svoboda J; Mato AR; Schuster SJ
Cancer; 2014 Jan; 120(2):222-8. PubMed ID: 24122387
[TBL] [Abstract][Full Text] [Related]
31. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
Lynch RC; Gratzinger D; Advani RH
Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
[TBL] [Abstract][Full Text] [Related]
32. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
34. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
Sréter L
Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
[TBL] [Abstract][Full Text] [Related]
35. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
37. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
38. [Recurrent somatic mutation in hairy cell leukemia].
Sári E; Nagy Z; Demeter J
Orv Hetil; 2013 Jan; 154(4):123-7. PubMed ID: 23335721
[TBL] [Abstract][Full Text] [Related]
39. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
